These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 23414473

  • 1. MITF, the Janus transcription factor of melanoma.
    Koludrovic D, Davidson I.
    Future Oncol; 2013 Feb; 9(2):235-44. PubMed ID: 23414473
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cell cycle inhibitor p21/ WAF1/ CIP1 as a cofactor of MITF expression in melanoma cells.
    Sestáková B, Ondrusová L, Vachtenheim J.
    Pigment Cell Melanoma Res; 2010 Apr; 23(2):238-51. PubMed ID: 20067556
    [Abstract] [Full Text] [Related]

  • 6. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.
    Buscà R, Berra E, Gaggioli C, Khaled M, Bille K, Marchetti B, Thyss R, Fitsialos G, Larribère L, Bertolotto C, Virolle T, Barbry P, Pouysségur J, Ponzio G, Ballotti R.
    J Cell Biol; 2005 Jul 04; 170(1):49-59. PubMed ID: 15983061
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MITF in melanoma: mechanisms behind its expression and activity.
    Hartman ML, Czyz M.
    Cell Mol Life Sci; 2015 Apr 04; 72(7):1249-60. PubMed ID: 25433395
    [Abstract] [Full Text] [Related]

  • 9. Pathways from senescence to melanoma: focus on MITF sumoylation.
    Leclerc J, Ballotti R, Bertolotto C.
    Oncogene; 2017 Nov 30; 36(48):6659-6667. PubMed ID: 28825724
    [Abstract] [Full Text] [Related]

  • 10. A germline oncogenic MITF mutation and tumor susceptibility.
    Paillerets BB, Lesueur F, Bertolotto C.
    Eur J Cell Biol; 2014 Nov 30; 93(1-2):71-5. PubMed ID: 24290354
    [Abstract] [Full Text] [Related]

  • 11. Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF.
    Anghel SI, Correa-Rocha R, Budinska E, Boligan KF, Abraham S, Colombetti S, Fontao L, Mariotti A, Rimoldi D, Ghanem GE, Fisher DE, Lévy F, Delorenzi M, Piguet V.
    Pigment Cell Melanoma Res; 2012 Jul 30; 25(4):482-7. PubMed ID: 22594792
    [Abstract] [Full Text] [Related]

  • 12. MITF-High and MITF-Low Cells and a Novel Subpopulation Expressing Genes of Both Cell States Contribute to Intra- and Intertumoral Heterogeneity of Primary Melanoma.
    Ennen M, Keime C, Gambi G, Kieny A, Coassolo S, Thibault-Carpentier C, Margerin-Schaller F, Davidson G, Vagne C, Lipsker D, Davidson I.
    Clin Cancer Res; 2017 Nov 15; 23(22):7097-7107. PubMed ID: 28855355
    [Abstract] [Full Text] [Related]

  • 13. Novel MITF targets identified using a two-step DNA microarray strategy.
    Hoek KS, Schlegel NC, Eichhoff OM, Widmer DS, Praetorius C, Einarsson SO, Valgeirsdottir S, Bergsteinsdottir K, Schepsky A, Dummer R, Steingrimsson E.
    Pigment Cell Melanoma Res; 2008 Dec 15; 21(6):665-76. PubMed ID: 19067971
    [Abstract] [Full Text] [Related]

  • 14. SWI/SNF chromatin remodeling complex is critical for the expression of microphthalmia-associated transcription factor in melanoma cells.
    Vachtenheim J, Ondrusová L, Borovanský J.
    Biochem Biophys Res Commun; 2010 Feb 12; 392(3):454-9. PubMed ID: 20083088
    [Abstract] [Full Text] [Related]

  • 15. The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression.
    Schepsky A, Bruser K, Gunnarsson GJ, Goodall J, Hallsson JH, Goding CR, Steingrimsson E, Hecht A.
    Mol Cell Biol; 2006 Dec 12; 26(23):8914-27. PubMed ID: 17000761
    [Abstract] [Full Text] [Related]

  • 16. Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells.
    Cheli Y, Giuliano S, Fenouille N, Allegra M, Hofman V, Hofman P, Bahadoran P, Lacour JP, Tartare-Deckert S, Bertolotto C, Ballotti R.
    Oncogene; 2012 May 10; 31(19):2461-70. PubMed ID: 21996743
    [Abstract] [Full Text] [Related]

  • 17. Microphthalmia-associated transcription factor expression levels in melanoma cells contribute to cell invasion and proliferation.
    Vachtenheim J, Ondrušová L.
    Exp Dermatol; 2015 Jul 10; 24(7):481-4. PubMed ID: 25866058
    [Abstract] [Full Text] [Related]

  • 18. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
    Kim A, Yang Y, Lee MS, Yoo YD, Lee HG, Lim JS.
    Pigment Cell Melanoma Res; 2008 Dec 10; 21(6):653-64. PubMed ID: 19067970
    [Abstract] [Full Text] [Related]

  • 19. SOX5 is involved in balanced MITF regulation in human melanoma cells.
    Kordaß T, Weber CE, Oswald M, Ast V, Bernhardt M, Novak D, Utikal J, Eichmüller SB, König R.
    BMC Med Genomics; 2016 Feb 29; 9():10. PubMed ID: 26927636
    [Abstract] [Full Text] [Related]

  • 20. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma.
    Strub T, Giuliano S, Ye T, Bonet C, Keime C, Kobi D, Le Gras S, Cormont M, Ballotti R, Bertolotto C, Davidson I.
    Oncogene; 2011 May 19; 30(20):2319-32. PubMed ID: 21258399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.